Ghent University Academic Bibliography

Show Sort by

Your filters: cql: keyword exact "immunotherapy" cql: author exact 000110722567 or (type exact bookEditor and editor exact 000110722567)

Add to list
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel Meireson (UGent) , Simon Tavernier (UGent) , Sofie Van Gassen (UGent) , Nora Sundahl, Annelies Demeyer (UGent) , Mathieu Spaas (UGent) , Vibeke Kruse (UGent) , Liesbeth Ferdinande (UGent) , Jo Van Dorpe (UGent) , Benjamin Hennart, et al.

(2021) CANCERS. 13(11).
Add to list
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora Sundahl, Gillian Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson (UGent) , Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) EUROPEAN UROLOGY. 75(5). p.707-711
Add to list
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

Nora Sundahl, Katrien De Wolf, Vibeke Kruse (UGent) , Annabel Meireson (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Mireille Van Gele (UGent) , Reinhart Speeckaert (UGent) , Benjamin Hennart, Lieve Brochez (UGent) , et al.

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.906-915
Add to list
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora Sundahl, Katrien De Wolf, Sylvie Rottey (UGent) , Karel Decaestecker (UGent) , Daan De Maeseneer (UGent) , Annabel Meireson (UGent) , Els Goetghebeur (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , et al.

(2017) JOURNAL OF TRANSLATIONAL MEDICINE. 15.

Academic Bibliography

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Contents

Support

Contact